Xiangjin J. Zheng
Key Laboratory Of Drug Target Research And Drug Screen, Chinese Academy Of Medical Science And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Efficacy of conversion therapy and prognostic factors in patients with synchronous gastric cancer liver metastasis
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: May 20, 2026
GD3s-mediated lipid metabolism reprograming promotes proliferation and metastasis of melanoma.
Journal: Journal of translational medicine
Published: December 21, 2025
IFI30 reprograms glioblastoma-associated macrophage and induces immune evasion by MAFF/PTGS2 pathway.
Journal: Acta pharmaceutica Sinica. B
Published: April 28, 2025
IFI30 promotes tumor-associated macrophage infiltration via activation of the ATF3-CCL5 axis in breast cancer.
Journal: Innovation (Cambridge (Mass.))
Published: February 09, 2025
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway.
Journal: Clinical epigenetics
Published: December 28, 2024
Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China.
Journal: Frontiers in pharmacology
Published: December 04, 2024
Erratum: Author correction to '3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312].
Journal: Acta pharmaceutica Sinica. B
Published: September 02, 2024
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Journal: Signal transduction and targeted therapy
Published: July 13, 2024
Corrigendum to "Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis" [Pharmacol. Res. 2022 Sep:183:106376].
Journal: Pharmacological research
Published: June 14, 2024
Corrigendum to "Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence" [Pharmacol. Res. 181 (2022), 106259].
Journal: Pharmacological research
Published: June 14, 2024
Progress on diagnostic and prognostic markers of pancreatic cancer.
Journal: Oncology research
Published: January 17, 2023
Correction: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 02, 2022
Last Updated: 09/26/2026